Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SWS Hemodialysis Care CoSHSE:688410 +1.27%89 PS Ratio is 5.88 as of Aug. 05, 2026, which is 15% below its 10-year median of 6.93. GuruFocus rates SHSE:688410 with a GF Score™ of 89/100 and a GF Value™ of ¥15.48 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 804 Medical Devices & Instruments companies, SWS Hemodialysis Care Co ranks worse than 74% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, SWS Hemodialysis Care Co's share price is ¥11.20.
SWS Hemodialysis Care Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ¥1.91. Hence, SWS Hemodialysis Care Co's PS Ratio for today is 5.88.
The historical rank and industry rank for SWS Hemodialysis Care Co's PS Ratio or its related term are showing as below:
SHSE:688410'
s PS Ratio Range Over the Past 10 Years
Min: 4.38 Med: 6.93 Max: 15.08
Current: 5.88
During the past 12 years, SWS Hemodialysis Care Co's highest PS Ratio was 15.08. The lowest was 4.38. And the median was 6.93.
SHSE:688410's PS Ratio is ranked worse than 74% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.98
vs SHSE:688410: 5.88
During the past 12 months, the average Revenue per Share Growth Rate of SWS Hemodialysis Care Co was 43.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 28.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 17.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 22.30% per year.
During the past 12 years, SWS Hemodialysis Care Co's highest 3-Year average Revenue per Share Growth Rate was 40.40% per year. The lowest was -28.30% per year. And the median was 21.40% per year.
SWS Hemodialysis Care Co (SHSE:688410) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688410 vs ISRG, BDX, MDLN: PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, SWS Hemodialysis Care Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SWS Hemodialysis Care Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where SWS Hemodialysis Care Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
SWS Hemodialysis Care Co's Share Price of today is ¥11.20. SWS Hemodialysis Care Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.91.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
SWS Hemodialysis Care Co (SHSE:688410) has a PS Ratio of 5.88 as of Aug. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on SWS Hemodialysis Care Co and its competitors. This is 15% below median its historical median of 6.93. Over the past decade, SWS Hemodialysis Care Co's PS Ratio has ranged from 4.38 to 15.08. According to the industry distribution chart, SWS Hemodialysis Care Co ranks #595 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 74%.
Is SWS Hemodialysis Care Co's PS Ratio too high?
SWS Hemodialysis Care Co's current PS Ratio of 5.88 is 15% below median its 10-year median of 6.93. Over the past 10 years, this metric has ranged from a low of 4.38 to a high of 15.08. The Medical Devices & Instruments industry median PS Ratio is 2.98. SWS Hemodialysis Care Co's value of 5.88 is 97.3% above this industry median. Based on the distribution chart, SWS Hemodialysis Care Co ranks #595 out of 804 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SWS Hemodialysis Care Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SWS Hemodialysis Care Co's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SWS Hemodialysis Care Co ranks #595 out of 804 companies for PS Ratio. This places SWS Hemodialysis Care Co in the lower half of its industry. The industry median PS Ratio is 2.98. SWS Hemodialysis Care Co's value of 5.88 is 97.3% above this benchmark. Historically, SWS Hemodialysis Care Co's own PS Ratio has ranged from 4.38 to 15.08 over the past decade. While the company's 10-year median is 6.93 vs. the industry median of 2.98, SWS Hemodialysis Care Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.98, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SWS Hemodialysis Care Co's current PS Ratio of 5.88 is 97.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on SWS Hemodialysis Care Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SWS Hemodialysis Care Co's current PS Ratio is 5.88, which is 15% below median its own 10-year median of 6.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SWS Hemodialysis Care Co stock overvalued right now?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co (SHSE:688410) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥15.48, compared to a current price of ¥11.20 — trading 27.6% below its estimated fair value. The current PS Ratio is 5.88, which is 15% below median its 10-year median of 6.93 and 97.3% above the Medical Devices & Instruments industry median of 2.98. SWS Hemodialysis Care Co's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For SWS Hemodialysis Care Co (SHSE:688410), the current PS Ratio is 5.88 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued.
The current stock price of ¥11.20 is trading 27.6% below its estimated GF Value™ of ¥15.48.
GuruFocus considers SWS Hemodialysis Care Co to be Modestly Undervalued.
Key valuation signals for SHSE:688410:
PS Ratio: 5.88 (15% below median its 10-year median of 6.93)
GF Value™: ¥15.48 vs. price of ¥11.20 (27.6% below fair value)
Industry Position: 97.3% above the Medical Devices & Instruments median (#595 of 804)
No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
89GF Score
Get the complete analysis for SHSE:688410
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688410 has been successfully added to your 
